Ingrid Lai

Mount Sinai Hospital

Papers

1

Total Citations

41

H-Index

1

About

Ingrid Lai is a developmental biologist whose research focuses on the molecular mechanisms governing early mammalian embryogenesis, particularly the role of ooplasmic factors in embryo viability. Her most-cited work, "Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development" (2011, 41 citations), represents a significant technical and conceptual contribution to the field. In this study, Lai demonstrated that precisely delivering the anti-apoptotic protein BCL-X into fertilized mouse eggs via automated microinjection can improve cleavage rates, blastocyst formation, and implantation potential. This finding not only highlights BCL-X as a critical ooplasmic factor for developmental success but also introduces an innovative, high-precision method for manipulating early embryos. By bridging cell survival signaling with assisted reproductive technology, Lai’s work has implications for both basic developmental biology and clinical applications in fertility treatment. Her research underscores how targeted protein supplementation can rescue compromised embryos, offering a potential pathway to enhance outcomes in mammalian reproduction. With her focused expertise in oocyte maturation and preimplantation development, Lai continues to advance our understanding of the molecular foundations of life’s earliest stages.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development
41 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Mount Sinai Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago